Skip to main content

Sensigen Lands Loan from Michigan Economic Development Group

NEW YORK (GenomeWeb News) – Molecular diagnostics company Sensigen said today it plans to use a loan at 1 percent interest from the Michigan Economic Development Corporation to expand its operations in Ann Arbor.
 
The company, which is developing diagnostic tests for human papillomavirus, chronic kidney disease, lupus, and other diseases, will use the money from the loan to hire workers that have been displaced by the closing of a Pfizer facility in Michigan.
 
The company’s molecular diagnostics technology, which combines mass spectrometry and PCR, was developed by University of Michigan researcher David Kurnit.
 
MEDC is a partnership between the State of Michigan and local communities that promote economic growth and development strategies.
 
Further terms of the loan agreement were not released.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.